MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

30 Apr 2026 Evaluate
Net sales declined -18.55%  to  Rs. 98.81 million from Rs. 121.31 millions.The Net Loss for the quarter ended March 2026 is Rs. -31.50 millions as compared to Net Profit of Rs. 12.29 millions of corresponding quarter ended March 2025Operating profit for the quarter ended March 2026 decreased to 7.69 millions as compared to 49.62 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 98.81 121.31 -18.55 436.14 430.47 1.32 436.14 430.47 1.32
Other Income 5.96 4.93 20.89 23.09 15.49 49.06 23.09 15.49 49.06
PBIDT 7.69 49.62 -84.50 114.98 157.29 -26.90 114.98 157.29 -26.90
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 8.23 49.13 -83.25 113.03 176.52 -35.97 113.03 176.52 -35.97
Depreciation 17.58 17.27 1.80 71.13 69.60 2.20 71.13 69.60 2.20
PBT -9.35 31.86 -129.35 41.90 106.92 -60.81 41.90 106.92 -60.81
TAX 22.15 19.57 13.18 52.61 50.79 3.58 52.61 50.79 3.58
Deferred Tax -1.79 -5.36 -66.60 47.72 25.86 84.53 47.72 25.86 84.53
PAT -31.50 12.29 -356.31 -10.71 56.13 -119.08 -10.71 56.13 -119.08
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 7.78 40.90 -80.97 26.36 36.54 -27.85 26.36 36.54 -27.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..